In the last several years iPSC reprogramming services from cells to induced pluripotent stem cells (iPSCs) has become increasingly common among researchers and pharmaceutical companies. The process of iPSC generation involves the reprogramming of a mature, terminally differentiated cell into a pluripotent one, which has the ability to differentiate into any cell type in the […]
We are proud to be the sole distributor for the National Institute of Neurological Disorders and Stroke (NINDS). The repository contains extensive biomaterials that can be requested by scientists worldwide. The NINDS biobank stem cell collection currently contains 411 subjects, 169 of which have iPSC and 270 of which have fibroblasts and represents several neurodegenerative […]
iPSCs hold massive potential for research and clinical therapies. However, if they are not properly validated, they could lead to inaccurate findings. In this article we cover the four validation studies that should be carried out on iPSCs throughout your investigation.